• HSBC

European stocks rally

  • Monday, July 24 - 2006 at 12:31

European stocks had the biggest weekly gain this month on speculation that earnings growth will be sustained and a two-year run of US interest-rate increases may soon end.

MARKET OUTLOOK

- US: US stocks rose this week as Federal Reserve Chairman Ben Bernanke foreshadowed an end to the central bank's two-year campaign of interest-rate increases.


- EUROPE: European stocks had the biggest weekly gain this month on speculation that earnings growth will be sustained and a two-year run of US interest-rate increases may soon end.



COMPANY PREVIEW


Merck (USD 37.36 ; 3.35% ; MRK ; MRK.N)

Merck publishes its results on Monday. The market expects the group to issue an EPS of $0.65, up from the $0.63 posted last year. The company declared that EPS will increase at "a rate in the double digits" between 2007 and 2010.


McDonald's (USD 34.7 ; 5.02% ; MCD ; MCD.N)

McDonald's reports its results Tuesday. The market will be looking for an EPS of $0.57. The group was recently raised to "outperform" from "inline" by Goldman Sachs.


BP (GBp 619.5 ; -3.66% ; BP/ ; BP.L)

BP reports 2Q results on Tuesday. The group, who had recently shut a dozen wells on Alaska's North Slope to investigate leaks of material, has failed to remove the sludge from the pipelines, a step needed to prevent another massive oil leak (FT).


Altria (USD 79.67 ; 2.95% ; MO ; MO.N)

Altria reports its 2Q results on Tuesday. EPS is seen at $1.37, down from the $1.40 it reported last year, on revenue of $17.87bln. The stock's target price was recently raised to $105 from $85 by JPMorgan.


ConocoPhillips (USD 63.63 ; -5.66% ; COP ; COP.N)

On Wednesday ConocoPhillips reports its 2Q results. The market will be looking for an EPS of $2.80, up from $2.21 a year ago on revenue which is expected to have surged 41% to $53.12bln. 1Q EPS reached $2.34, against $2.06 the year before. The group is undervalued at a time when prices for crude oil are reaching records highs (Business Week).



Article Options

Disclaimer »

The information comprised in this section is not, nor is it held out to be, a solicitation of any person to take any form of investment decision. The content of the AMEinfo.com Web site does not constitute advice or a recommendation by AME Info FZ LLC / Emap Limited and should not be relied upon in making (or refraining from making) any decision relating to investments or any other matter. You should consult your own independent financial adviser and obtain professional advice before exercising any investment decisions or choices based on information featured in this AMEinfo.com Web site.

AME Info FZ LLC / Emap Limited can not be held liable or responsible in any way for any opinions, suggestions, recommendations or comments made by any of the contributors to the various columns on the AMEinfo.com Web site nor do opinions of contributors necessarily reflect those of AME Info FZ LLC / Emap Limited.

In no event shall AME Info FZ LLC / Emap Limited be liable for any damages whatsoever, including, without limitation, direct, special, indirect, consequential, or incidental damages, or damages for lost profits, loss of revenue, or loss of use, arising out of or related to the AMEinfo.com Web site or the information contained in it, whether such damages arise in contract, negligence, tort, under statute, in equity, at law or otherwise.


Internaxx Disclaimer:
This content in this section was prepared by the research department of MeesPierson and Fortis Global Markets. This document does not constitute financial advice. If you require such advice, you should seek appropriate professional advice.

Internaxx accepts no responsibility for the content of in this section.